Depressive syndromes in schizophrenic patients under neuroleptic therapy. ANI Study Group Berlin, Düsseldorf, Göttingen, Munich, Federal Republic of Germany.

Bandelow, B; Müller, P; Frick, U; Gaebel, W; Linden, M; Müller-Spahn, F; Pietzcker, A; Tegeler, J

Bandelow, B; Müller, P; Frick, U; Gaebel, W; Linden, M; Müller-Spahn, F; Pietzcker, A; Tegeler, J.

Affiliation

Bandelow B; Department of Psychiatry, University of Göttingen, Federal Republic of Germany.

Eur Arch Psychiatry Clin Neurosci ; 241(5): 291-5, 1992.

Article in En | MEDLINE | ID: mdl-1351405

Subject(s)

Antipsychotic Agents/adverse effects; Depressive Disorder/complications; Schizophrenia/complications; Administration, Oral; Antipsychotic Agents/administration & dosage; Basal Ganglia Diseases/complications; Basal Ganglia Diseases/physiopathology; Delayed-Action Preparations; Depressive Disorder/chemically induced; Depressive Disorder/psychology; Humans; Psychiatric Status Rating Scales; Schizophrenia/drug therapy

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Schizophrenia / Antipsychotic Agents / Depressive Disorder Type of study: Clinical_trials Limits: Humans Language: En Journal: Eur Arch Psychiatry Clin Neurosci Journal subject: NEUROLOGIA / PSIQUIATRIA Year: 1992 Document type: Article Country of publication: Germany

Search on Google

Add to My VHL

XML

PubMed Links